Abstract
The efficacy of hyperbaric oxygen therapy in treating wound healing disorders is well established. The obvious explanation is the presence of elevated oxygen tissue tensions during the high-pressure oxygen exposure. This explanation omits that the effective agent, elevated oxygen tension, is only present for 6.25% of the time. To investigate possible prevailing vascular changes caused by HBOT, the presented device monitors the vascular response during therapy by Pulse-Transit-Time analysis. The device allows synchronous 1 kHz ECG and PPG measurements. The data are stored in a 1 GBit flash drive and retrieved post-therapy. Normoxic measurements on the authors with and without nicotine validate the device's functionality. Measurements during HBO therapy have been successfully performed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
